Impact-driven

Biosimilars

Get in touch

Biosimilarity isn’t discovered. It’s engineered.

Precision in every molecule.

Your pure-play
biosimilar developer with an
international track record.

Built to accelerate biosimilar pipelines.

Approved biosimilars

8

Years biologics expertise

12+

Regulatory standards

EMA · FDA

Partners worwide

8

Operating from Zug

Switzerland

Global reach

EU · US · MENA +

WHAT WE DO

We produce impact
driven biosimilars. From
concept to end market.

that most biosimilar programs don’t fail on science. They fail at the transitions.

The molecule isn’t the risk.
The transitions are.

is to keep every program seemlessly moving as one system, from concept to commercial supply.

Full biosimilar lifecycle.
One global development strategy.

We know

Our goal